← Back to grants
Grant✓ Small businesses may apply

NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)

National Institutes of Health

Award ceiling

$475,000

Award floor

$475,000

Program funding

$23,000,000

Opportunity #
RFA-RM-27-002
Agency
National Institutes of Health
ALN (CFDA)
93.310
Status
posted
Posted
Jun 26, 2026
Closes
Aug 17, 2026
Funding instrument
Grant
Category
Health
Cost sharing required
No

Who can apply

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Synopsis

The NIH Director"s New Innovator Award supports early-stage investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. Applications in any area within the biomedical sciences are welcome; topics may involve basic, translational, or clinical research. The NIH Director's New Innovator Award complements other ongoing efforts by NIH and its Institutes and Centers to fund early-stage investigators. The NIH Director"s New Innovator Award is a component of the High-Risk, High-Reward Research (HRHR) program of the NIH Common Fund.

Contact

National Institutes of Health · NewInnovatorAwards@mail.nih.gov

View full notice on Grants.gov ↗